Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells

Daker,Maelinda; Bhuvanendran,Saatheeyavaane; Ahmad,Munirah; Takada,Kenzo; Khoo,Alan  Soo‑Beng

doi:10.3892/mmr.2012.1253

Deregulation of lipid metabolism pathway genes in nasopharyngeal carcinoma cells

Authors:
- Maelinda Daker
- Saatheeyavaane Bhuvanendran
- Munirah Ahmad
- Kenzo Takada
- Alan Soo‑Beng Khoo
View Affiliations

Affiliations: Molecular Pathology Unit, Cancer Research Centre, Institute for Medical Research, Kuala Lumpur 50588, Malaysia, Department of Tumour Virology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan
Published online on: December 28, 2012 https://doi.org/10.3892/mmr.2012.1253
Pages: 731-741
Copyright: © Daker et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Nasopharyngeal carcinoma (NPC) is a unique tumour of epithelial origin with a distinct geographical distribution, closely associated with the Epstein‑Barr virus (EBV). EBV‑encoded RNAs (EBERs) are small non‑polyadenylated RNAs that are abundantly expressed in latent EBV‑infected NPC cells. To study the role of EBERs in NPC, we established stable expression of EBERs in HK1, an EBV‑negative NPC cell line. Cells expressing EBERs consistently exhibited an increased growth rate. However, EBERs did not confer resistance towards cisplatin‑induced apoptosis or promote migration or invasion ability in the cells tested. Using microarray gene expression profiling, we identified potential candidate genes that were deregulated in NPC cells expressing EBERs. Gene Ontology analysis of the data set revealed that EBERs upregulate the cellular lipid metabolic process. Upregulation of low‑density lipoprotein receptor (LDLR) and fatty acid synthase (FASN) was observed in EBER‑expressing cells. NPC cells exhibited LDL‑dependent cell proliferation. In addition, a polyphenolic flavonoid compound, quercetin, known to inhibit FASN, was found to inhibit proliferation of NPC cells.

View Figures

View References

1	Tao Q and Chan AT: Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments. Exp Rev Mol Med. 9:1–24. 2007.PubMed/NCBI
2	Chou J, Lin YC, Kim J, You L, Xu Z, He B and Jablons DM: Nasopharyngeal carcinoma - review of the molecular mechanisms of tumorigenesis. Head Neck. 30:946–963. 2008. View Article : Google Scholar : PubMed/NCBI
3	Takada K and Nanbo A: The role of EBERs in oncogenesis. Semin Cancer Biol. 11:461–467. 2001. View Article : Google Scholar : PubMed/NCBI
4	Komano J, Maruo S, Kurozumi K, Oda T and Takada K: Oncogenic role of Epstein-Barr virus-encoded RNAs in Burkitt’s lymphoma cell line Akata. J Virol. 73:9827–9831. 1999.
5	Yamamoto N, Takizawa T, Iwanaga Y, Shimizu N and Yamamoto N: Malignant transformation of B lymphoma cell line BJAB by Epstein-Barr virus-encoded small RNAs. FEBS Lett. 484:153–158. 2000. View Article : Google Scholar : PubMed/NCBI
6	Kitagawa N, Goto M, Kurozumi K, Maruo S, Fukayama M, Naoe T, Yasukawa M, Hino K, Suzuki T, Todo S and Takada K: Epstein-Barr virus-encoded poly(A)(-) RNA supports Burkitt’s lymphoma growth through interleukin-10 induction. EMBO J. 19:6742–6750. 2000.PubMed/NCBI
7	Yang L, Aozasa K, Oshimi K and Takada K: Epstein-Barr virus (EBV)-encoded RNA promotes growth of EBV-infected T cells through interleukin-9 induction. Cancer Res. 64:5332–5337. 2004. View Article : Google Scholar : PubMed/NCBI
8	Wong HL, Wang X, Chang RC, et al: Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress. Mol Carcinog. 44:92–101. 2005. View Article : Google Scholar : PubMed/NCBI
9	Iwakiri D, Eizuru Y, Tokunaga M and Takada K: Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res. 63:7062–7067. 2003.PubMed/NCBI
10	Iwakiri D, Sheen TS, Chen JY, Huang DP and Takada K: Epstein-Barr virus-encoded small RNA induces insulin-like growth factor 1 and supports growth of nasopharyngeal carcinoma-derived cell lines. Oncogene. 24:1767–1773. 2005. View Article : Google Scholar : PubMed/NCBI
11	Huang DP, Ho JH, Poon YF, Chew EC, Saw D, Lui M, Li CL, Mak LS, Lai SH and Lau WH: Establishment of a cell line (NPC/HK1) from a differentiated squamous carcinoma of the nasopharynx. Int J Cancer. 26:127–132. 1980. View Article : Google Scholar : PubMed/NCBI
12	Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, Wong N, Whitney BM and Lee JC: Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer. 83:121–126. 1999. View Article : Google Scholar : PubMed/NCBI
13	Chan SY, Choy KW, Tsao SW, Tao Q, Tang T, Chung GT and Lo KW: Authentication of nasopharyngeal carcinoma tumor lines. Int J Cancer. 122:2169–2171. 2008. View Article : Google Scholar : PubMed/NCBI
14	Gebäck T, Schulz MM, Koumoutsakos P and Detmar M: TScratch: a novel and simple software tool for automated analysis of monolayer wound healing assays. Biotechniques. 46:265–274. 2008.PubMed/NCBI
15	Edgar R, Domrachev M and Lash AE: Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 30:207–210. 2002. View Article : Google Scholar : PubMed/NCBI
16	Busson P, Ganem G, Flores P, Mugneret F, Clausse B, Caillou B, Braham K, Wakasugi H, Lipinski M and Tursz T: Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas. Int J Cancer. 42:599–606. 1988. View Article : Google Scholar : PubMed/NCBI
17	Cory G: Scratch-wound assay. Cell Migration: Developmental Methods and Protocols, Methods in Molecular Biology. Wells CM and Parsons M: 769. Springer Science+Business Media, LLC; New York, NY: pp. 25–30. 2011, View Article : Google Scholar
18	Sturn A, Quackenbush J and Trajanoski Z: Genesis: cluster analysis of microarray data. Bioinformatics. 18:207–208. 2002. View Article : Google Scholar : PubMed/NCBI
19	Brusselmans K, Vrolix R, Verhoeven G and Swinnen JV: Induction of cancer cell apoptosis by flavonoids is associated with their ability to inhibit fatty acid synthase activity. J Biol Chem. 280:5636–5645. 2005. View Article : Google Scholar : PubMed/NCBI
20	Daker M, Ahmad M and Khoo ASB: Quercetin-induced inhibition and synergistic activity with cisplatin - a chemotherapeutic strategy for nasopharyngeal carcinoma cells. Cancer Cell Int. 12:342012. View Article : Google Scholar : PubMed/NCBI
21	Hirsch HA, Iliopoulos D, Joshi A, Zhang Y, Jaeger SA, Bulyk M, Tsichlis PN, Shirley Liu X and Struhl K: A transcriptional signature and common gene networks link cancer with lipid metabolism and diverse human diseases. Cancer Cell. 17:348–361. 2010. View Article : Google Scholar : PubMed/NCBI
22	Chung NS and Wasan KM: Potential role of the low-density lipoprotein receptor family as mediators of cellular drug uptake. Adv Drug Deliv Rev. 56:1315–1334. 2004. View Article : Google Scholar : PubMed/NCBI
23	Tatidis L, Gruber A and Vitols S: Decreased feedback regulation of low density lipoprotein receptor activity by sterols in leukemic cells from patients with acute myelogenous leukemia. J Lipid Res. 38:2436–2445. 1997.
24	Chen Y and Hughes-Fulford M: Human prostate cancer cells lack feedback regulation of low-density lipoprotein receptor and its regulator, SREBP2. Int J Cancer. 91:41–45. 2001. View Article : Google Scholar : PubMed/NCBI
25	Sekine Y, Koike H, Nakano T, Nakajima K, Takahashi S and Suzuki K: Remnant lipoproteins induced proliferation of human prostate cancer cell, PC-3 but not LNCaP, via low density liporprotein receptor. Cancer Epidemiol. 33:16–23. 2009. View Article : Google Scholar : PubMed/NCBI
26	Lum DF, McQuaid KR, Gilbertson VL and Hughes-Fulford M: Coordinate up-regulation of low-density lipoprotein receptor and cyclo-oxygenase-2 gene expression in human colorectal cells and in colorectal adenocarcinoma biopsies. Int J Cancer. 83:162–166. 1999. View Article : Google Scholar
27	Rao KN: The significance of the cholesterol biosynthetic pathway in cell growth and carcinogenesis (review). Anticancer Res. 15:309–314. 1995.PubMed/NCBI
28	Gueddari N, Favre G, Hachem H, Marek E, Le Gaillard F and Soula G: Evidence for up-regulated low density lipoprotein receptor in human lung adenocarcinoma cell line A549. Biochimie. 75:811–819. 1993. View Article : Google Scholar : PubMed/NCBI
29	Shiroeda O, Yamaguchi N and Kawai K: Stimulation of low density lipoprotein receptor activity by conditioned medium from a human cancer cell line. Cancer Res. 47:4630–4633. 1987.PubMed/NCBI
30	Shimano H: Sterol regulatory element-binding proteins (SREBPs): transcriptional regulators of lipid synthetic genes. Prog Lipid Res. 40:439–452. 2001. View Article : Google Scholar
31	Weber LW, Boll M and Stampfl A: Maintaining cholesterol homeostasis: sterol regulatory element-binding proteins. World J Gastroenterol. 10:3081–3087. 2004.PubMed/NCBI
32	Streicher R, Kotzka J, Müller-Wieland D, Siemeister G, Munck M, Avci H and Krone W: SREBP-1 mediates activation of the low density lipoprotein receptor promoter by insulin and insulin-like growth factor-1. J Biol Chem. 271:7128–7133. 1996. View Article : Google Scholar : PubMed/NCBI
33	Foretz M, Guichard C, Ferré P and Foufelle F: Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci USA. 12737–12742. 1999. View Article : Google Scholar
34	LaVoie HA, Garmey JC, Day RN and Veldhuis JD: Concerted regulation of low density lipoprotein receptor gene expression by follicle-stimulating hormone and insulin-like growth factor 1 in porcine granulosa cells: promoter activation, messenger ribonucleic acid stability and sterol feedback. Endocrinology. 140:178–186. 1999.
35	Kuhajda FP: Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition. 16:202–208. 2000. View Article : Google Scholar : PubMed/NCBI
36	Menendez JA and Lupu R: Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nat Rev Cancer. 7:763–777. 2007. View Article : Google Scholar : PubMed/NCBI
37	Kuhajda FP: Fatty acid synthase and cancer: new application of an old pathway. Cancer Res. 66:5977–5980. 2006. View Article : Google Scholar : PubMed/NCBI
38	Zhang F, Cui Y and Cao P: Effect of quercetin on proliferation and apoptosis of human nasopharyngeal carcinoma HEN1 cells. J Huazhong Univ Sci Technolog Med Sci. 28:369–372. 2008. View Article : Google Scholar : PubMed/NCBI
39	Yoshida M, Sakai T, Hosokawa N, Marui N, Matsumoto K, Fujioka A, Nishino H and Aoike A: The effect of quercetin on cell cycle progression and growth of human gastric cancer cells. FEBS Lett. 260:10–13. 1990. View Article : Google Scholar : PubMed/NCBI
40	Yoshida M, Yamamoto M and Nikaido T: Quercetin arrests human leukemic T-cells in late G1 phase of the cell cycle. Cancer Res. 52:6676–6681. 1992.PubMed/NCBI
41	Lupu R and Menendez JA: Pharmacological inhibitors of Fatty Acid Synthase (FASN)-catalyzed endogenous fatty acid biogenesis: a new family of anti-cancer agents? Curr Pharm Biotechnol. 7:483–493. 2006. View Article : Google Scholar : PubMed/NCBI
42	Pizer ES, Chrest FJ, DiGiuseppe JA and Han WF: Pharmacological inhibitors of mammalian fatty acid synthase suppress DNA replication and induce apoptosis in tumor cell lines. Cancer Res. 58:4611–4615. 1998.PubMed/NCBI